Related references
Note: Only part of the references are listed.Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria
Anna Hood et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Phenylketonuria Scientific Review Conference: State of the science and future research needs
Kathryn M. Camp et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Testing for Tetrahydrobiopterin Responsiveness in Patients with Hyperphenylalaninemia due to Phenylalanine Hydroxylase Deficiency
Roberto Cerone et al.
ADVANCES IN THERAPY (2013)
Psychiatric symptoms in adults with phenylketonuria
Deborah A. Bilder et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study
Stefanie Keil et al.
PEDIATRICS (2013)
The Mechanism of BH4-Responsive Hyperphenylalaninemia-As it Occurs in the ENU1/2 Genetic Mouse Model
Christineh N. Sarkissian et al.
HUMAN MUTATION (2012)
Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life
B. Ziesch et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
Jeanine R. Jarnes Utz et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Long-term treatment with tetrahydrobiopterin in phenylketonuria: Treatment strategies and prediction of long-term responders
Julia B. Hennermann et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?
Anita MacDonald et al.
BRITISH JOURNAL OF NUTRITION (2011)
The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response
Michael Staudigl et al.
HUMAN MOLECULAR GENETICS (2011)
Using change in plasma phenylalanine concentrations and ability to liberalize diet to classify responsiveness to tetrahydrobiopterin therapy in patients with phenylketonuria
Rani H. Singh et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies
Nenad Blau et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Activation of Phenylalanine Hydroxylase Induces Positive Cooperativity toward the Natural Cofactor
Soren W. Gersting et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation
Jytte Bieber Nielsen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
BH4 therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up
Rani H. Singh et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria
H. J. Vernon et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment
Friedrich K. Trefz et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy
Aurora Daniele et al.
FEBS JOURNAL (2009)
Effect of BH4 supplementation on phenylalanine tolerance
A. Burlina et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Phenylalanine tolerance can already reliably be assessed at the age of 2 years in patients with PKU
F. J. van Spronsen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Friedrich K. Trefz et al.
JOURNAL OF PEDIATRICS (2009)
Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes
Erin L. MacLeod et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Safety and Efficacy of 22 Weeks of Treatment With Sapropterin Dihydrochloride in Patients With Phenylketonuria
Phillip Lee et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria
Alberto Ponzone et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin):: a phase II, multicentre, open-label, screening study
B. K. Burton et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
Harvey L. Levy et al.
LANCET (2007)
Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria
Betina Fiege et al.
JOURNAL OF PEDIATRICS (2007)
Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy
N Lambruschini et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria
JB Hennermann et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Diffusion-weighted MR imaging in patients with phenylketonuria: Relationship between serum phenylalanine levels and ADC values in cerebral white matter
K Kono et al.
RADIOLOGY (2005)
Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria
AC Muntau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002
C Bernegger et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates
LJM Spaapen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)